GB0911796D0 - An extract - Google Patents

An extract

Info

Publication number
GB0911796D0
GB0911796D0 GBGB0911796.1A GB0911796A GB0911796D0 GB 0911796 D0 GB0911796 D0 GB 0911796D0 GB 0911796 A GB0911796 A GB 0911796A GB 0911796 D0 GB0911796 D0 GB 0911796D0
Authority
GB
United Kingdom
Prior art keywords
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0911796.1A
Other versions
GB2458599B (en
GB2458599A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SEPEREX NUTRITIONALS Ltd
Original Assignee
SEPEREX NUTRITIONALS Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SEPEREX NUTRITIONALS Ltd filed Critical SEPEREX NUTRITIONALS Ltd
Publication of GB0911796D0 publication Critical patent/GB0911796D0/en
Publication of GB2458599A publication Critical patent/GB2458599A/en
Application granted granted Critical
Publication of GB2458599B publication Critical patent/GB2458599B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Edible Oils And Fats (AREA)
  • Medicinal Preparation (AREA)
GB0911796A 2006-12-20 2007-12-18 Oil extract from a bivalve mollusc that is rich in N-acylethanolamides Expired - Fee Related GB2458599B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ552238A NZ552238A (en) 2006-12-20 2006-12-20 An extract
PCT/NZ2007/000370 WO2008075978A2 (en) 2006-12-20 2007-12-18 An extract

Publications (3)

Publication Number Publication Date
GB0911796D0 true GB0911796D0 (en) 2009-08-19
GB2458599A GB2458599A (en) 2009-09-30
GB2458599B GB2458599B (en) 2011-03-23

Family

ID=39536841

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0911796A Expired - Fee Related GB2458599B (en) 2006-12-20 2007-12-18 Oil extract from a bivalve mollusc that is rich in N-acylethanolamides

Country Status (9)

Country Link
KR (1) KR20090103918A (en)
CN (2) CN103638003A (en)
CA (1) CA2710054C (en)
DE (1) DE112007003136T5 (en)
GB (1) GB2458599B (en)
HK (1) HK1136218A1 (en)
NZ (1) NZ552238A (en)
TW (1) TWI405568B (en)
WO (1) WO2008075978A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS51647B (en) 2006-10-18 2011-10-31 Pfizer Products Inc. Biaryl ether urea compunds
NZ552238A (en) 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
BRPI0822603A2 (en) * 2008-04-28 2015-06-16 Vermont Italia Srl Pharmaceutical formulation containing palmitoyl ethanolamine and stearoyl ethanolamine.
NZ575985A (en) * 2009-03-31 2010-04-30 Bomac Research Ltd Medicament Uptake
GB0909643D0 (en) 2009-06-04 2009-07-22 Avexxin As Glomerulonephritis treatment
ITPD20090360A1 (en) * 2009-12-01 2011-06-02 Vermont Italia Srl COMPOSITION FOR TOPICAL USE
CN102811628A (en) * 2010-02-04 2012-12-05 蒙奈尔化学感觉中心 Compounds and methods for enhancing salty taste
GB201014633D0 (en) 2010-09-02 2010-10-13 Avexxin As Rheumatoid arthritis treatment
ES2648051T3 (en) * 2010-10-04 2017-12-28 Epitech Group S.P.A. Use of mono and dicarboxylic acid amides in the treatment of kidney diseases
FR2965478B1 (en) * 2010-10-05 2015-04-24 Oreal USE OF ANANDAMIDE TO CONTROL SKIN DROUGHT
WO2012070905A2 (en) * 2010-11-26 2012-05-31 Kim Young-Moon Mollusk extract for preventing or treating rare and intractable diseases of the human body
CN103113253A (en) * 2013-01-28 2013-05-22 国家海洋局第三海洋研究所 Alcohol amine derivative of unsaturated fatty acid and preparation method and application thereof
ITMI20130354A1 (en) 2013-03-08 2014-09-09 Again Life Italia Srl MIXTURE OF FATTY ACIDS (F.A.G. FATTY ACIDS GROUP) FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES.
CA2914760A1 (en) * 2013-06-07 2014-12-11 Loma Linda University Dietary omega-3 fatty acid derived glycerophospholipids to treat neuropathic pain
GB201409363D0 (en) 2014-05-27 2014-07-09 Avexxin As Skin cancer treatment
DK3177281T3 (en) * 2014-08-08 2024-03-11 Ali Res S R L MIXTURE OF FATTY ACIDS AND PALMITOYLET THANOLAMIDE FOR USE IN THE TREATMENT OF INFLAMMATORY AND ALLERGIC PATHOLOGIES
US10966937B2 (en) * 2015-05-04 2021-04-06 Cytometix, Inc. Compositions and methods for delivery of polyunsaturated fatty acid derivatives and analogs
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
WO2018055062A1 (en) 2016-09-21 2018-03-29 Avexxin As Pharmaceutical composition
US20200016215A1 (en) * 2016-12-20 2020-01-16 Sanford Limited Bioactive mussel compositions and/or extracts
AU2017380471B2 (en) * 2016-12-23 2023-12-21 Mm Health Ltd Topical formulation comprising green lipped mussel and honey

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801453A (en) 1984-05-01 1989-01-31 James M. Broadbent Stabilized mussel extract
NZ328489A (en) 1994-07-22 1999-06-29 Mcfarlane Lab New Zealand Ltd Extraction of glycogen from green lipped mussels and use as an anti-inflammatory agent
NZ270754A (en) 1995-03-20 1997-08-22 Mcfarlane Lab Nz Ltd Mussel/fish oil mixture; finely ground, freeze-dried green-lipped mussel (perna canaliculus) suspended in fish oil; encapsulated mixture with anti-inflammatory activity
AUPN531195A0 (en) 1995-09-11 1995-10-05 J.W. Broadbent Nominees Pty. Ltd. Lipid extract having anti-inflamatory activity
NZ314867A (en) 1997-05-21 1999-04-29 Mcfarlane Lab New Zealand Ltd Glucosamine and mussel extract compositions for use as anti-inflammatories
NZ329018A (en) 1998-12-22 2000-04-28 Ind Res Ltd Extracting glycogen from Green Shell Mussels and the use of the glycogen as a food supplement or additive or in the treatment of inflammatory diseases such as arthritis.
US6596303B1 (en) 1999-03-22 2003-07-22 Mars Incorporated Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals
CN1304988A (en) * 2000-06-09 2001-07-25 山东绿叶制药股份有限公司 Mussel oil and its preparing process and application
NZ510407A (en) 2001-03-08 2004-05-28 Healtheries Of New Zealand Ltd Mussel extract derivative with anti-inflammatory activity
NZ552238A (en) 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract

Also Published As

Publication number Publication date
CA2710054A1 (en) 2008-06-26
TW200833318A (en) 2008-08-16
WO2008075978A3 (en) 2008-07-31
WO2008075978A2 (en) 2008-06-26
CA2710054C (en) 2012-11-20
GB2458599B (en) 2011-03-23
DE112007003136T5 (en) 2009-11-19
GB2458599A (en) 2009-09-30
CN101641089A (en) 2010-02-03
TWI405568B (en) 2013-08-21
HK1136218A1 (en) 2010-06-25
CN101641089B (en) 2013-06-12
KR20090103918A (en) 2009-10-01
NZ552238A (en) 2009-07-31
CN103638003A (en) 2014-03-19

Similar Documents

Publication Publication Date Title
GB0911796D0 (en) An extract
EP2078282A4 (en) E-couponing
EP2033216A4 (en) Electroadhesion
DE602007008085D1 (en) Dihydropyrazolopyrimidinonderivate
DE602007014031D1 (en) Luftreifensatz
DE602007003855D1 (en) Isothermer reaktor
EP1983992A4 (en) 2-imino-benzimidazoles
DE602007001601D1 (en) Glasuntersuchung
DE602007006989D1 (en) Spiropiperidinderivate
AP2008004724A0 (en) Substituted1-yl)-azolin-2-aryl-1-hetaryl-ethane
EP2024567A4 (en) Earthen-wallpaper
GB2452595B (en) An insert
GB2442979B (en) Extraction unit
EP2007388A4 (en) Opiopathies
GB0713585D0 (en) Equivalent
DE602007003815D1 (en) Men
DK1989111T3 (en) Satellitluftbremseapparat
DE502007001126D1 (en) Eiten
GB0601584D0 (en) Cosyhold headscarf
AU3514P (en) ARCBENT Arctotis fastuosa
AU4914P (en) CalflatGL Calothamnus quadrifidus
GB0612322D0 (en) Simple
GB0612341D0 (en) Suitable
GB0605449D0 (en) 4c
GB0601581D0 (en) Stannseal

Legal Events

Date Code Title Description
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1136218

Country of ref document: HK

REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1136218

Country of ref document: HK

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20141218